ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
AgomAb Therapeutics
14.01
+1.19
9.28%
成交量:
19.22萬
成交額:
263.45萬
市值:
6.90億
市盈率:
-8.95
高:
14.25
開:
13.40
低:
13.16
收:
12.82
52周最高:
17.82
52周最低:
8.75
股本:
4,924.80萬
流通股本:
1,383.60萬
量比:
2.95
換手率:
1.39%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.5649
每股收益(LYR):
-168.1598
淨資產收益率:
-39.22%
總資產收益率:
-20.58%
市淨率:
6.39
市盈率(LYR):
-0.08
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
AgomAb Therapeutics
交易所:
NASDAQ
成立時間:
2017
員工人數:
- -
公司地址:
Posthoflei 1/6,Antwerp,Antwerp,Belgium
官網:
http://www.agomab.com
郵編:
2600
電話:
32 3 318 91 70
傳真:
- -
簡介:
AgomAb Therapeutics NV最初於2017年4月13日根據比利時法律註冊成立為比利時私人有限責任公司,並於2019年3月14日轉換為比利時有限責任公司。該公司是一家臨床階段的生物製藥公司,專註於為存在高度未滿足醫療需求的纖維炎症性疾病開發新型疾病修飾療法。
董事
名稱
職位
David Epstein
Chairman of the Board and Director
Tim Knotnerus
Chief Executive Officer and Executive Director
Angelika Jahreis
Non-Executive Director
Colin Bond
Non-Executive Director
Felice Verduyn van Weegen
Non-Executive Director
Ohad Hammer
Non-Executive Director
股東
名稱
職位
Tim Knotnerus
Chief Executive Officer and Executive Director
Pierre Kemula
Chief Financial Officer
Andrea Saez
Chief Development Officer
Ellen Lefever
General Counsel
Paul van der Horst
Chief Business Officer
Philippe Wiesel
Chief Medical Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/AGMB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":14.01,"timestamp":1787685759034,"preClose":12.82,"halted":0,"volume":192246,"delay":0,"changeRate":0.0928237129485179,"floatShares":13836000,"shares":49248000,"eps":-1.5648936,"marketStatus":"交易中","change":1.19,"latestTime":"08-25 15:22:57 EDT","open":13.4,"high":14.25,"low":13.16,"amount":2634460.36314,"amplitude":0.085023,"askPrice":14.08,"askSize":100,"bidPrice":13.94,"bidSize":122,"shortable":3,"etf":0,"ttmEps":-1.5648936,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":12.82,"preHourTrading":{"tag":"盘前","latestPrice":13.3,"preClose":12.82,"latestTime":"08:41 EDT","volume":47,"amount":622.850016,"timestamp":1787661663477,"change":0.48,"changeRate":0.037441,"amplitude":0.0117},"postHourTrading":{"tag":"盘后","latestPrice":12.82,"preClose":12.82,"latestTime":"19:30 EDT","volume":8,"amount":102.56,"timestamp":1787614207230,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.945843},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":13836000,"roa":"-20.58%","roe":"-39.22%","lyrEps":-168.159829,"volumeRatio":2.945843,"shares":49248000,"dividePrice":0,"high":14.25,"amplitude":0.085023,"preClose":12.82,"low":13.16,"week52Low":8.75,"pbRate":"6.39","week52High":17.82,"institutionHeld":0,"latestPrice":14.01,"committee":0.099099,"eps":-1.5648936,"divideRate":0,"volume":192246,"delay":0,"ttmEps":-1.5648936,"open":13.4,"prevYearClose":16,"prevWeekClose":13.25,"prevMonthClose":12.87,"prevQuarterClose":12.98,"fiveDayClose":13.73,"twentyDayClose":12.54,"sixtyDayClose":11.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1787371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGMB","date":"2026-08-24","current":-8.997417,"percent":0.651852,"low":-14.725744,"twenty":-12.400375,"median":-8.978348,"eighty":-7.793482,"high":-6.52172,"avg":-9.67543,"sd":2.281087,"marketCap":652535668},"quantilePoints":[{"date":"2026-02-06","current":-14.293959,"twenty":-14.293959,"median":-14.293959,"eighty":-14.293959,"marketCap":779788464},{"date":"2026-02-13","current":-13.901135,"twenty":-14.202947,"median":-13.85921,"eighty":-13.805127,"marketCap":763217959},{"date":"2026-02-20","current":-13.975141,"twenty":-14.020702,"median":-13.811207,"eighty":-13.436782,"marketCap":760781120},{"date":"2026-02-27","current":-14.297833,"twenty":-14.274685,"median":-13.837477,"eighty":-13.631029,"marketCap":780275831},{"date":"2026-03-06","current":-12.944797,"twenty":-14.315694,"median":-13.869306,"eighty":-13.479283,"marketCap":692549629},{"date":"2026-03-13","current":-12.71107,"twenty":-14.294734,"median":-13.805127,"eighty":-12.961754,"marketCap":677928595},{"date":"2026-03-20","current":-11.600011,"twenty":-14.274685,"median":-13.584093,"eighty":-12.695924,"marketCap":618957093},{"date":"2026-03-27","current":-10.84065,"twenty":-14.216331,"median":-13.160447,"eighty":-12.395453,"marketCap":578505566},{"date":"2026-04-02","current":-10.748527,"twenty":-14.066263,"median":-13.052487,"eighty":-11.414439,"marketCap":574119256},{"date":"2026-04-10","current":-9.193391,"twenty":-13.930737,"median":-12.827934,"eighty":-10.709469,"marketCap":497602513},{"date":"2026-04-17","current":-10.018749,"twenty":-13.86294,"median":-12.650405,"eighty":-9.901184,"marketCap":545851924},{"date":"2026-04-24","current":-9.622204,"twenty":-13.825362,"median":-12.457995,"eighty":-9.650988,"marketCap":521483535},{"date":"2026-05-01","current":-7.206485,"twenty":-13.809991,"median":-11.744798,"eighty":-9.486381,"marketCap":528794052},{"date":"2026-05-08","current":-7.639457,"twenty":-13.779732,"median":-11.111376,"eighty":-9.258769,"marketCap":562411874},{"date":"2026-05-15","current":-7.446972,"twenty":-13.702513,"median":-10.748527,"eighty":-8.300034,"marketCap":543697644},{"date":"2026-05-22","current":-7.434647,"twenty":-13.568448,"median":-10.364346,"eighty":-8.115636,"marketCap":538772846},{"date":"2026-05-29","current":-7.796965,"twenty":-13.4527,"median":-9.998785,"eighty":-7.794875,"marketCap":568321631},{"date":"2026-06-05","current":-8.053102,"twenty":-13.287949,"median":-9.784729,"eighty":-7.758816,"marketCap":585558422},{"date":"2026-06-12","current":-6.750851,"twenty":-13.127527,"median":-9.578953,"eighty":-7.536224,"marketCap":486569993},{"date":"2026-06-18","current":-6.929006,"twenty":-13.073014,"median":-9.501773,"eighty":-7.448225,"marketCap":497404547},{"date":"2026-06-26","current":-9.2886,"twenty":-13.035188,"median":-9.467948,"eighty":-7.458553,"marketCap":661400304},{"date":"2026-07-02","current":-8.166663,"twenty":-12.965993,"median":-9.467948,"eighty":-7.479819,"marketCap":584573463},{"date":"2026-07-10","current":-8.975013,"twenty":-12.944797,"median":-9.309036,"eighty":-7.532768,"marketCap":641701114},{"date":"2026-07-17","current":-8.479177,"twenty":-12.71107,"median":-9.193391,"eighty":-7.541408,"marketCap":606735052},{"date":"2026-07-24","current":-8.981683,"twenty":-12.707304,"median":-9.020605,"eighty":-7.554336,"marketCap":638746235},{"date":"2026-07-31","current":-8.723327,"twenty":-12.661785,"median":-8.978348,"eighty":-7.610114,"marketCap":628157921},{"date":"2026-08-07","current":-9.22434,"twenty":-12.557349,"median":-9.00807,"eighty":-7.636377,"marketCap":664847662},{"date":"2026-08-14","current":-8.931525,"twenty":-12.519309,"median":-9.035172,"eighty":-7.716456,"marketCap":686763011},{"date":"2026-08-21","current":-8.496488,"twenty":-12.423423,"median":-8.981683,"eighty":-7.781927,"marketCap":661400304},{"date":"2026-08-24","current":-8.390444,"twenty":-12.400375,"median":-8.978348,"eighty":-7.793482,"marketCap":652535668}],"updateTime":1787682818119},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":563168576,"yearFounded":2017,"address":"Posthoflei 1/6,Antwerp,Antwerp,Belgium","zipCode":"2600","officePhone":"32 3 318 91 70","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.agomab.com","stockEarnings":[{"period":"1week","weight":-0.0629},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.1602},{"period":"6month","weight":-0.2042},{"period":"1year","weight":-0.1987},{"period":"ytd","weight":-0.1987}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"AgomAb Therapeutics NV最初於2017年4月13日根據比利時法律註冊成立為比利時私人有限責任公司,並於2019年3月14日轉換為比利時有限責任公司。該公司是一家臨床階段的生物製藥公司,專註於為存在高度未滿足醫療需求的纖維炎症性疾病開發新型疾病修飾療法。","exchange":"NASDAQ","name":"AgomAb Therapeutics","nameEN":"AgomAb Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":{"directors":[{"name":"David Epstein","position":"Chairman of the Board and Director"},{"name":"Tim Knotnerus","position":"Chief Executive Officer and Executive Director"},{"name":"Angelika Jahreis","position":"Non-Executive Director"},{"name":"Colin Bond","position":"Non-Executive Director"},{"name":"Felice Verduyn van Weegen","position":"Non-Executive Director"},{"name":"Ohad Hammer","position":"Non-Executive Director"}],"executives":[{"name":"Tim Knotnerus","position":"Chief Executive Officer and Executive Director"},{"name":"Pierre Kemula","position":"Chief Financial Officer"},{"name":"Andrea Saez","position":"Chief Development Officer"},{"name":"Ellen Lefever","position":"General Counsel"},{"name":"Paul van der Horst","position":"Chief Business Officer"},{"name":"Philippe Wiesel","position":"Chief Medical Officer"}]}}}